Zhejiang Zhenyuan Co., Ltd. operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Zhenyuan Co., Ltd. with three other
companies in this sector in China:
Jiangsu Nhwa Pharmaceutical Company Limited
sales of 3.02 billion Chinese Renmimbi [US$479.23 million]
of which 55%
was Medical Industrial Manufacturing),
China Resources Phoenix Healthcare Holdings Co Ltd
(1.53 billion Chinese Renmimbi [US$243.46 million]
of which 53%
was GPO business), and
China Pioneer Pharma Holdings Ltd
(1.79 billion Chinese Renmimbi [US$284.35 million]
of which 57%
was Products sold via the provision of co-pr).
Zhejiang Zhenyuan Co., Ltd. reported sales of 2.44 billion Chinese Renmimbi (US$387.50 million)
December of 2016.
increase of 12.8%
versus 2015, when the company's sales were 2.16 billion Chinese Renmimbi.
Sales at Zhejiang Zhenyuan Co., Ltd. have increased during each of the previous five years
(and since 2011, sales have increased a total of 42%).
Sales of Medicine Wholesales saw an increase
21.0% in 2016, from
1.69 billion Chinese Renmimbi to 2.05 billion Chinese Renmimbi.
Not all segments of Zhejiang Zhenyuan Co., Ltd. experienced an increase in sales in 2016:
sales of Medicines Manufacturing fell 0.2% to 344.87 million Chinese Renmimbi.